Imricor Medical Systems, Inc Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
|Primary activities||Development of MRI-compatible medical devices to carry out MRI-guided cardiac catheter ablation procedures.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||400 Gateway Boulevard Burnsville MN 55337 United States|
|Phone / Fax||952 818 8400 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Imricor Medical Systems, Inc does not pay dividends.
As of May 2021, following are the company executives and directors listed on Imricor Medical Systems, Inc.
|Mr. Steve Wedan||CEO, Pres & Exec. Chairman||51||565k|
|Ms. Lori Milbrandt||CFO & VP of Fin.||362.25k|
|Mr. Gregg Stenzel||Chief Operating Officer|
|Mr. Greg Englehardt||Exec. Director of Sales|
|Mr. Nick Twohy||Exec. Director of Marketing|
|Mr. Kobe Lizheng||Company Sec. & Local Agent|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Imricor Medical Systems, Inc is 220.54M and its enterprise value is 217.16M. The enterprise value to revenue ratio of IMR is 309.27.
Companies similar to Imricor Medical Systems, Inc (IMR)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Imricor Medical Systems, Inc (ASX:IMR) Frequently Asked Questions
1. What is Imricor Medical Systems, Inc's Stock Symbol?
Imricor Medical Systems, Inc trades on ASX under the ticker symbol "IMR".
2. What is Imricor Medical Systems, Inc's stock price today?
One share of IMR stock can currently be purchased for approximately $1.91.
3. How can I contact Imricor Medical Systems, Inc?
Imricor Medical Systems, Inc's mailing address is 400 Gateway Boulevard Burnsville MN 55337 United States. The company can be reached via phone at 952 818 8400.
4. What is Imricor Medical Systems, Inc's official website?
The official website of Imricor Medical Systems, Inc is http://www.imricor.com.
5. Which share registry manages Imricor Medical Systems, Inc's stock?
Imricor Medical Systems, Inc's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.